(Skip Definitions and go directly to clinical criteria) Definitions

Transvenous implantable cardiac defibrillator (ICD) (Aka thoracotomy systems)
Device designed to monitor heart rate, recognize ventricular fibrillation (VF) or ventricular tachycardia (VT) and deliver electrical shock to terminate these arrhythmias in order to reduce the risk of sudden cardiac death (SCD). The reasons for device-implantation are twofold:
1. Primary prevention -those patients at high risk for SCD who have not experienced life-threatening VTs or VF 2. Secondary prevention -those patients who have experienced a potentially lifethreatening episode of VT (i.e., near SCD)
The standard ICD involves placement of a generator in the subcutaneous tissue of the chest wall. Transvenous leads are attached to the generator and threaded intravenously into the endocardium. The leads sense and transmit information on cardiac rhythm to the generator which analyzes the rhythm information and produces an electrical shock when a malignant arrhythmia is recognized.
Subcutaneous implantable cardiac defibrillator (S-ICD) (Aka nonthoracotomy systems)
A defibrillator device that is implanted is implanted under the skin on the side of the chest below the arm pit. The pulse generator is connected to the electrode which is implanted under the skin from the device pocket along the rib margin to the breastbone with the use of the insertion tool. The electrodes sense the cardiac rhythm and deliver countershocks through the subcutaneous tissue of the chest wall.
The S-ICD does not require a thoracotomy and does not employ transvenous leads. The goal of this device is to reduce lead-related complications. Problems that affect the electrical system of the heart muscle, producing abnormal heart rhythms and may be classified as either atrial or ventricular, depending on which part of the heart they originate from.
Atrial fibrillation A condition in which the atrium (the heart's two upper chambers) produce uncoordinated electrical signals.
Ejection fraction (EF) or left ventricular ejection fraction (LVEF)
Percentage of blood ejected from the left ventricle with each heartbeat Normal LVEF readings are in the 58-70% range.
QRS complex
Refers to a portion of a tracing within an electrocardiogram that represents the spread of the electrical impulse through the ventricles. A prolonged QRS interval indicates a dyssynchrony of the right and left ventricle and is an important selection criterion for a biventricular pacemaker.
Cardiac arrest (CA)
Sudden cardiac death (SCD)
A cardiac arrest is triggered by an electrical malfunction in the heart that causes arrhythmia. (This differs from a "heart attack, which is secondary to impeded blood flow [i.e. myocardial infarction])
Sudden cardiac death is the result of an abrupt loss of heart function (i.e., cardiac arrest)
Cardiomyopathy (CM) A disease in which the heart muscle becomes inflamed affecting cardiac function. There are multiple types of CM, (with the three main types being dilated, hypertrophic and restrictive:  Dilated -the most common form, in which the heart cavity is enlarged and stretched (cardiac dilation). The heart is weak and doesn't pump normally, and most individuals develop congestive heart failure. Abnormal heart rhythms and disturbances in the heart's electrical conduction may also occur.
 Hypertrophic (HCM) -the muscle mass of the left ventricle enlarges or "hypertrophies." In one form of the disease, the wall between the two pumping chambers becomes enlarged and obstructs the blood flow from the left ventricle. In the other form of the disease, non-obstructive hypertrophic cardiomyopathy, the enlarged muscle doesn't obstruct blood flow.
 Ischemic Dilated (IDCM) -left ventricular systolic dysfunction associated with marked stenosis (at least 75% narrowing) of at least one of the three major coronary arteries or a documented history of MI.
 Nonischemic Dilated (NIDCM) -left ventricular systolic dysfunction (or disease of the heart muscle) that is not associated with coronary artery disease (CAD) or narrowing of the coronary arteries. There are a few different types of NIDCM, but all involve thickening of the walls of the heart and progressive weakening of the pumping efficiency of the heart.
 Restrictive -the least common type in the United States. The myocardium of the ventricles becomes excessively "rigid," making it more difficult for the ventricles to fill with blood between heartbeats. This type of cardiomyopathy is usually due to another disease process.
Myocardial infarction (MI)
A myocardial infarction (aka heart attack) is a clinical (or pathologic) event caused by myocardial ischemia in which there is evidence of myocardial injury or necrosis.
Prior MI is defined as any of the following:
 Pathological Q waves with or without symptoms in the absence of nonischemic causes  Imaging evidence of a region of loss of viable myocardium that is thinned and fails to contract in the absence of a non-ischemic cause  Pathological findings of a prior MI Condition in which the heart's electrical activity becomes disordered. When this happens, the heart's lower (pumping) chambers contract in a rapid, unsynchronized fashion (the ventricles "quiver" rather than beat) and the heart pumps little or no blood.
Ventricular tachyarrhythmias Rapid heartbeat that may be regular or irregular arising from the ventricle or pumping chamber of the heart. Two common tachyarrhythmias are ventricular tachycardia and ventricular fibrillation.
Ventricular tachycardia (Vtach or VT)
Fast regular heart rate that starts in the lower chambers (ventricles). VT may result from serious heart disease and usually requires prompt treatment. Class IV (Severe): Unable to carry out any physical activity without discomfort. Symptoms of cardiac insufficiency at rest. If any physical activity is undertaken, discomfort is increased.
Related Medical Guidelines
Automatic External Defibrillators Cardiac Resynchronization Therapy (Biventricular Pacing)
Guideline Implantable cardiac defibrillation therapy using an FDA-approved ICD (thoracotomy system) or S-ICD (non-thoracotomy system) is considered medically necessary when the following criteria (I-III) are met:
I. Transvenous ICD -adults
Considered medically necessary when member is not a candidate for cardiac revascularization (i.e., coronary artery bypass graft [CABG] or percutaneous transluminal coronary angioplasty [PTCA]) is not clinically appropriate and one of the following criteria (1 or 2) is met:
1. Primary prevention -high SCD risk without occurrence of a life-threatening VT or VF and ≥ 1 (a-i):
a. Ischemic cardiomyopathy with NYHA functional Class I symptoms and both: Note: EmblemHealth considers the use of a FDA-approved implantable cardioverter defibrillator (ICD) device, combined with cardiac resynchronization therapy (i.e., CRT/ICD), to be medically necessary in cases of NYHA Class IV heart failure and other indications when the plan's Resynchronization (Biventricular Pacing) Medical Guideline criteria are met in addition to the ICD criteria below.
Limitations/Exclusions
The use of either a subcutaneous or transvenous ICD is considered investigational and not medically necessary for clinical conditions other than those listed above, as well as when the specific criteria are not met.
Implantable cardioverter defibrillators with a built -in ST-segment monitoring feature (aka ICD -based ischemia monitors) are not considered medically necessary for any indication (in adults or children) due to insufficient evidence of therapeutic value.
Cardioverter-defibrillators are not considered medically necessary when other disease processes are present that clearly and severely limit estimated life expectancy to less than one 1 year.
The replacement of an ICD pulse generator/leads is considered medically necessary when:
1. Equipment is damaged or malfunctioning 2. Manufacturer product labeling details medically necessary replacement scenario(s) 3. Change in member's medical condition Electrophysiologic evaluation of subcutaneous implantable defibrillator (includes defibrillation threshold evaluation, induction of arrhythmia, evaluation of sensing for arrhythmia termination, and programming or reprogramming of sensing or therapeutic parameters)
93745
Initial set-up and programming by a physician or other qualified health care professional of wearable cardioverter-defibrillator includes initial programming of system, establishing baseline electronic ECG, transmission of data to data repository, patient instruction in wearing system and patient reporting of problems or events
G0448
Insertion or replacement of a permanent pacing cardioverter-defibrillator system with transvenous lead(s), single or dual chamber with insertion of pacing electrode, cardiac venous system, for left ventricular pacing 
